(NASDAQ: MEDP)
New York, New York--(Newsfile Corp. - February 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ: MEDP)...
The 5 Most Interesting Analyst Questions From Medpace’s Q4 Earnings Call
1 Cash-Producing Stock with Competitive Advantages and 2 That Underwhelm
MEDP Q4 Deep Dive: Cancellations and Metabolic Trial Mix Pressure Margins Despite Strong Growth
Medpace (NASDAQ:MEDP) Reports Bullish Q4 CY2025
Revenue of $708.5 million in the fourth quarter of 2025 increased 32.0% from revenue of $536.6 million for the comparable prior-year period, representing a backlog conversion rate of 23.6%. ...
Earnings To Watch: Medpace (MEDP) Reports Q4 Results Tomorrow
3 Market-Beating Stocks to Consider Right Now